These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 34262865)

  • 1. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cell Plasticity - A Deadly Deal.
    Thankamony AP; Saxena K; Murali R; Jolly MK; Nair R
    Front Mol Biosci; 2020; 7():79. PubMed ID: 32426371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
    Paul R; Dorsey JF; Fan Y
    Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.
    Ravindran S; Rasool S; Maccalli C
    Cancer Microenviron; 2019 Dec; 12(2-3):133-148. PubMed ID: 31758404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cell Plasticity Drives Therapeutic Resistance.
    Doherty MR; Smigiel JM; Junk DJ; Jackson MW
    Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26742077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers.
    Shang W; Zhang Q; Huang Y; Shanti R; Alawi F; Le A; Jiang C
    J Dent Res; 2018 Jun; 97(6):654-664. PubMed ID: 29486673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
    Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
    Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness.
    Hass R; von der Ohe J; Ungefroren H
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.
    Correnti M; Binatti E; Gammella E; Invernizzi P; Recalcati S
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response.
    Lorenzo-Sanz L; Muñoz P
    Cancer Microenviron; 2019 Dec; 12(2-3):119-132. PubMed ID: 31583529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.
    Limonta P; Chiaramonte R; Casati L
    Cancers (Basel); 2024 Aug; 16(16):. PubMed ID: 39199632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.